DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Butylphthalide is an investigational drug.
There have been 14 clinical trials for Butylphthalide. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2015.
The most common disease conditions in clinical trials are Stroke, Cerebral Infarction, and Ischemia. The leading clinical trial sponsors are CSPC-NBP Pharmaceutical Co., Ltd., The Second Hospital of Hebei Medical University, and Peking Union Medical College Hospital.
Recent Clinical Trials for Butylphthalide
|NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events||Peking University International Hospital||Phase 3|
|NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events||yuanli Zhao||Phase 3|
|Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion||The Second Hospital of Hebei Medical University||Phase 4|